Synthesized for advanced in-vitro evaluation and receptor binding analysis, Kaiser Labs Tirzepatide delivers a high-purity dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist peptide designed for rigorous laboratory study and scientific research protocols. Strict quality assurance guarantees precise batch formulation and structural integrity for your experimental benchmarks. Please note: This product is strictly for research use only and is not intended for human or animal consumption.

• Purity: >99% laboratory grade

• Net Quantity: 10mg per vial

• Application: FOR RESEARCH USE ONLY

• Primary Focus: Receptor binding assays, metabolic pathway evaluation, and scientific research protocols